Boroujeni Mahdi Eskandarian, Gardaneh Mossa
Department of Stem Cells and Regenerative Medicine, Faculty of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Karaj HWY Kilometer 15, P.O. Box 14965/161, Tehran, Iran.
Mol Biotechnol. 2018 Mar;60(3):185-193. doi: 10.1007/s12033-017-0044-5.
Viral gene delivery is hailed as a great milestone in gene-based therapeutic approaches. The human immunodeficiency virus-derived lentiviral vectors (LVs) are advantageous in infecting both dividing and non-dividing cells leading to continuous expression of transgenes. A variety of protocols are available for concentration of LVs. We primarily generated our internal ribosome entry site (IRES)-based LVs. Virus titration and transduction efficiency were compared between various strategies that included sucrose cushion centrifugation (SCC), protein column ultrafiltration and polyethylene glycol precipitation. Among these approaches, SCC resulted in concentration of high-titer EGFP-expressing lentivirus (1.4 ± 0.3 × 10 TU/ml) with the lowest protein impurities. Further, we examined transduction strengths of our three methods on two challenging stem cells. Both human NT2 and mouse bone marrow-derived mesenchymal stem cells demonstrated high transduction using SCC of 65 ± 2.8 and 49 ± 0.8%, respectively. Finally, lentivirus particles harboring IRES-based transfer vectors of specific genes, concentrated by SCC, integrated into host genome. Taken together, development of cost-effective and efficient concentration strategies such as our SCC method is yet highly demanded to broaden the horizons of lentivirus application in clinical and translational research.
病毒基因递送被誉为基于基因的治疗方法中的一个重大里程碑。源自人类免疫缺陷病毒的慢病毒载体(LVs)在感染分裂细胞和非分裂细胞方面具有优势,可导致转基因的持续表达。有多种用于浓缩慢病毒载体的方案。我们主要构建了基于内部核糖体进入位点(IRES)的慢病毒载体。在包括蔗糖垫层离心(SCC)、蛋白柱超滤和聚乙二醇沉淀在内的各种策略之间比较了病毒滴度和转导效率。在这些方法中,SCC导致高滴度表达EGFP的慢病毒(1.4±0.3×10 TU/ml)浓缩,且蛋白质杂质最少。此外,我们在两种具有挑战性的干细胞上检测了这三种方法的转导强度。人NT2细胞和小鼠骨髓间充质干细胞使用SCC时的转导效率分别高达65±2.8%和49±0.8%。最后,通过SCC浓缩的携带特定基因的基于IRES的转移载体的慢病毒颗粒整合到宿主基因组中。综上所述,开发如我们的SCC方法这样具有成本效益且高效的浓缩策略对于拓宽慢病毒在临床和转化研究中的应用范围仍然有很高的需求。